Loading...
NPI 1760825624 · Paducah, KY · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Brian Bodnarchuk is a ophthalmology physician provider located in Paducah, Kentucky. This profile covers 24 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Brian Bodnarchuk |
| Address | 4630 Village Square Dr |
| City | Paducah |
| State | KY |
| ZIP | 42001 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | April 10, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.3M |
| Medicaid | $52.3K |
This provider’s Medicare activity is highly concentrated in anti-VEGF and cataract services: the top three Medicare codes (J0178, J2778, 66984) account for 77.0% of total Medicare revenue, with J0178 (aflibercept injections) alone representing $1.4M and 60.7% of Medicare revenue. That mix indicates a practice built around intravitreal pharmacologic therapy with supplemental surgical cataract volume rather than a broad multispecialty ophthalmology case mix.
Medicare revenue ($2.3M) dwarfs Medicaid revenue ($52.3K), so the provider is effectively Medicare-dominant in scale; Medicaid represents a small fraction of overall public-payer receipts and is not a primary revenue driver for this clinician. The asymmetric payer mix suggests Medicare-focused patient panels and reimbursement exposure concentrated in the senior population.
Competitive standing on key Medicare codes is mixed: J0178 ranks #517 of 3204 (84th percentile), indicating above-average national volume for aflibercept injections relative to peers, while 66984 ranks #2255 of 15965 (86th percentile) showing solid cataract surgery placement in the national distribution. By contrast, other commonly billed services have more modest national positions, so the provider is a meaningful but not dominant national participant for these high-revenue procedures.
There are clear statistical outliers in the provider’s Medicare E/M and imaging patterns: 99213 ranks in the 98th percentile nationally and is described as "notably above typical national volume," indicating unusually high established-patient E/M activity for an ophthalmology specialty. Even more pronounced, 99204 is flagged as an "extreme outlier, far above typical national volume" (100th percentile), suggesting atypically high billing for moderate-complexity new-patient encounters on Medicare.
Retina diagnostic imaging is another prominent Medicare service line: 92134 ranks in the 96th percentile and is labeled "notably above typical national volume," supporting the view that retinal disease management and monitoring are central to the clinical workflow beyond just injection procedures. Complementary CPTs such as 92136 (94th percentile) further corroborate above-average utilization of pre- and post-operative biometric and retinal imaging services.
On Medicaid, revenue is also concentrated: the top three Medicaid codes (67028, 92134, 99213) account for 82.4% of total Medicaid revenue, with 67028 (intravitreal injection) contributing $20.9K or 40.1% of Medicaid receipts. However, the provider’s in-state rankings for those Medicaid codes are modest—67028 is 23rd percentile in-state and 92134 is 64th percentile—indicating the provider is not a leading Medicaid injection or retina-imaging center within Kentucky.
Operational implication: the predominance of high-revenue infusion codes (J0178, J2778) on Medicare combined with strong retinal imaging and E/M volumes suggests a clinical model organized around frequent follow-up visits and in-office procedures for chronic retinal conditions. This pattern typically aligns with retina-focused ophthalmology practices that manage ongoing anti-VEGF treatment regimens and monitoring rather than episodic surgical-only workflows.
Tenure and stability: the NPI was enumerated on 2013-04-10 (~13 years ago), indicating an established presence in the market. Given the sustained high share of revenue from recurring-injection codes and diagnostic imaging, the practice appears to have an enduring treatment-focused referral base for retinal disease in the Medicare population.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
24 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 2,050 | $690 | $1.4M |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,220 | $180 | $221K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 790 | $200 | $157.8K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 5,220 | $30 | $151.4K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,290 | $90 | $114.5K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,970 | $30 | $51.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 860 | $60 | $47K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 330 | $100 | $33.4K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 110 | $270 | $30.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 340 | $80 | $26.8K |
Showing 1–10 of 24
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
24 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 13 | 40 | 870 | $690 | $858.5K |
| J2777 | 23 | 30 | 11,040 | $30 | $399.1K |
| J2778 | 2 | 20 | 700 | $180 | $148.3K |
| 67028 | 15 | 50 | 650 | $90 | $72.9K |
| 66984 | 193 | 310 | 1,560 | $40 | $67.1K |
| 66991 | 10 | 10 | 30 | $1,390 | $43K |
| 66982 | 60 | 70 | 30 | $270 | $20.8K |
| J3590 | 10 | 40 | 160 | $60 | $17K |
| 66821 | 40 | 160 | 50 | $110 | $16.1K |
| 99214 | 1,233 | 7,230 | 110 | $70 | $14.1K |
Showing 1–10 of 24
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 130 | $160 | $20.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 400 | $30 | $11.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 280 | $40 | $10.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 120 | $70 | $8.9K |
| 92136 | The provider uses a noninvasive method to measure the patient’s eye or eyes to get information that the provider then uses to calculate the appropriate power for an intraocular lens (IOL). Selecting… | 20 | $20 | $340 |
How this provider's Medicaid billing volume and revenue compare to other Kentucky providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kentucky median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,298 | 3,340 | 1,020 | $30 | $296K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 24 | 30 | 350 | $70 | $165.3K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 710 | 1,400 | 130 | $50 | $45.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 27 | 70 | 210 | $20 | $29.2K |
| 92136 | The provider uses a noninvasive method to measure the patient’s eye or eyes to get information that the provider then uses to calculate the appropriate power for an intraocular lens (IOL). Selecting… | 34 | 40 | 80 | $10 | $8.1K |
Other providers in the same ZIP code as Brian Bodnarchuk, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.